Equity Overview
Price & Market Data
Price: $22.40
Daily Change: +$0.175 / 0.78%
Daily Range: $22.27 - $22.78
Market Cap: $0
Daily Volume: 19,619
Performance Metrics
1 Week: 3.51%
1 Month: 13.48%
3 Months: 22.24%
6 Months: -2.47%
1 Year: -22.14%
YTD: -6.44%
Details
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.